mohd izzuan
- Amgen (NASDAQ:AMGN) released 2025 revenue and guidance ranges as part of its 2024 Q4 and full-year financial results after Tuesday’s closing bell, and both include the consensus figures.
- Revenues are projected to be $34.3B-$35.7B. Consensus is $34.53B. Non-GAAP EPS is estimated at $20.00-$21.20. Consensus is $20.82.
